Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Percudani, Mauro
and
Knapp, Martin
1998.
The economic perspective in the care and treatment of patients with diagnosis of schizophrenia.
Epidemiologia e Psichiatria Sociale,
Vol. 7,
Issue. 3,
p.
197.
Lader, Malcolm
1998.
The relevance of recent advances in psychopharmacology for social psychiatry.
Epidemiologia e Psichiatria Sociale,
Vol. 7,
Issue. 2,
p.
77.
Waddington, John L.
Youssef, Hanafy A.
and
Kinsella, Anthony
1998.
Mortality in schizophrenia.
British Journal of Psychiatry,
Vol. 173,
Issue. 4,
p.
325.
Wilhelm, Kay
1998.
The Relevance of Smoking and Nicotine to Clinical Psychiatry.
Australasian Psychiatry,
Vol. 6,
Issue. 3,
p.
130.
1998.
Review: patients who have schizophrenia have increased mortality from all causes, natural causes, and unnatural causes.
Evidence Based Mental Health,
Vol. 1,
Issue. 3,
p.
91.
Harrison, Paul J.
1999.
The neuropathology of schizophrenia.
Brain,
Vol. 122,
Issue. 4,
p.
593.
Horrobin, D. F.
and
Bennett, C. N.
1999.
Search for the Causes of Schizophrenia.
p.
261.
Landén, Mikael
Davidsson, Pia
Gottfries, Carl-Gerhard
Stridsberg, Bengt GrenfeldtMats
and
Blennow, Kaj
1999.
Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia.
Biological Psychiatry,
Vol. 46,
Issue. 12,
p.
1698.
Kilian, Jens G
Kerr, Kristin
Lawrence, Christopher
and
Celermajer, David S
1999.
Myocarditis and cardiomyopathy associated with clozapine.
The Lancet,
Vol. 354,
Issue. 9193,
p.
1841.
Percudani, M.
Fattore, G.
Galletta, J.
Mita, P. L.
Contini, A.
and
Altamura, A. C.
1999.
Health care costs of therapy‐refractory schizophrenic patients treated with clozapine: a study in a community psychiatric service in Italy.
Acta Psychiatrica Scandinavica,
Vol. 99,
Issue. 4,
p.
274.
Hewer, W.
1999.
Psychiatrie der Gegenwart 4.
p.
289.
Landén, Mikael
Grenfeldt, Bengt
Davidsson, Pia
Stridsberg, Mats
Regland, Björn
Gottfries, Carl-Gerhard
and
Blennow, Kaj
1999.
Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia.
European Neuropsychopharmacology,
Vol. 9,
Issue. 4,
p.
311.
Santhouse, Alistair
and
Holloway, Frank
1999.
Physical health of patients in continuing care.
Advances in Psychiatric Treatment,
Vol. 5,
Issue. 6,
p.
455.
Fenton, Wayne S.
2000.
Depression, Suicide, and Suicide Prevention in Schizophrenia.
Suicide and Life-Threatening Behavior,
Vol. 30,
Issue. 1,
p.
34.
Lara, D.R.
and
Souza, D.O.
2000.
Schizophrenia: a purinergic hypothesis.
Medical Hypotheses,
Vol. 54,
Issue. 2,
p.
157.
Davidson, Sandra
Judd, Fiona
Jolley, Damien
Hocking, Barbara
and
Thompson, Sandra
2000.
The General Health Status of People with Mental Illness.
Australasian Psychiatry,
Vol. 8,
Issue. 1,
p.
31.
De Hert, Marc
and
Peuskens, Jozef
2000.
The International Handbook of Suicide and Attempted Suicide.
p.
121.
Goldman, Larry S.
2000.
Comorbid medical illness in psychiatric patients.
Current Psychiatry Reports,
Vol. 2,
Issue. 3,
p.
256.
Jordan, Sue
Philpin, Sue
Davies, Shân
and
Andrade, Maria
2000.
The biological sciences in mental health nursing: stakeholders’ perspectives.
Journal of Advanced Nursing,
Vol. 32,
Issue. 4,
p.
881.
Green, Alan I
Patel, Jayendra K
Goisman, Robert M
Allison, David B
and
Blackburn, George
2000.
Weight gain from novel antipsychotic drugs: need for action.
General Hospital Psychiatry,
Vol. 22,
Issue. 4,
p.
224.
eLetters
No eLetters have been published for this article.